Weili Wang

4.7k total citations
175 papers, 3.6k citations indexed

About

Weili Wang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Weili Wang has authored 175 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 46 papers in Oncology and 42 papers in Molecular Biology. Recurrent topics in Weili Wang's work include Lung Cancer Diagnosis and Treatment (24 papers), Advanced Radiotherapy Techniques (16 papers) and Effects of Radiation Exposure (14 papers). Weili Wang is often cited by papers focused on Lung Cancer Diagnosis and Treatment (24 papers), Advanced Radiotherapy Techniques (16 papers) and Effects of Radiation Exposure (14 papers). Weili Wang collaborates with scholars based in China, United States and Taiwan. Weili Wang's co-authors include Feng‐Ming Kong, Stephen Safe, Jian‐Yue Jin, Brad Saville, Mitchell Machtay, Xiaonan Wang, Zhengtao Liu, Zhenguang Yan, Yuanbiao Zhang and Ismael Samudio and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Weili Wang

163 papers receiving 3.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Weili Wang 1.1k 676 671 556 378 175 3.6k
Ken Takeda 1.3k 1.2× 598 0.9× 1.3k 1.9× 1.1k 2.0× 492 1.3× 272 5.6k
Shinji Abe 917 0.8× 607 0.9× 1.3k 2.0× 247 0.4× 503 1.3× 211 3.7k
Sarah Baatout 1.4k 1.3× 552 0.8× 701 1.0× 1.2k 2.2× 291 0.8× 199 4.5k
Chengcheng Zhang 2.2k 2.0× 699 1.0× 543 0.8× 841 1.5× 367 1.0× 185 4.1k
Manuel Scimeca 893 0.8× 496 0.7× 332 0.5× 238 0.4× 394 1.0× 132 2.9k
Jeffrey I. Everitt 2.1k 1.9× 737 1.1× 1.3k 2.0× 269 0.5× 470 1.2× 196 6.5k
Takuya Nishimura 901 0.8× 180 0.3× 202 0.3× 190 0.3× 169 0.4× 131 2.3k
Chun Chen 1.5k 1.4× 929 1.4× 1.3k 1.9× 288 0.5× 350 0.9× 362 4.6k
Hiroshi Sasaki 941 0.9× 269 0.4× 454 0.7× 127 0.2× 195 0.5× 204 3.3k
Xin Zhang 2.4k 2.2× 329 0.5× 395 0.6× 280 0.5× 333 0.9× 253 5.8k

Countries citing papers authored by Weili Wang

Since Specialization
Citations

This map shows the geographic impact of Weili Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weili Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weili Wang more than expected).

Fields of papers citing papers by Weili Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weili Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weili Wang. The network helps show where Weili Wang may publish in the future.

Co-authorship network of co-authors of Weili Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Weili Wang. A scholar is included among the top collaborators of Weili Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weili Wang. Weili Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Weili, et al.. (2025). WAVEN: WebAssembly Memory Virtualization for Enclaves. 1 indexed citations
3.
Yang, Fan, et al.. (2025). Study on Particle Sedimentation in a Cavity Containing Obstacles. Processes. 13(4). 980–980.
6.
Wei, Shu‐Yi, et al.. (2024). Identification of KU-55933 as an anti-atherosclerosis compound by using a hemodynamic-based high-throughput drug screening platform. Proceedings of the National Academy of Sciences. 121(5). e2318718121–e2318718121. 2 indexed citations
7.
Jones, David R., Moïshe Liberman, Terufumi Kato, et al.. (2024). OA01.03 Association of Pathologic Regression with EFS in the KEYNOTE-671 Study of Perioperative Pembrolizumab for Early-Stage NSCLC. Journal of Thoracic Oncology. 19(10). S8–S8. 5 indexed citations
8.
Zhang, Hui, et al.. (2023). Antibacterial and anti-inflammatory effects of PGLa-loaded TiO2 nanotube arrays. Frontiers in Chemistry. 11. 1210425–1210425. 2 indexed citations
9.
Xu, Kai, Weili Wang, Chao Wang, et al.. (2023). Characterization of a crustin-like peptide involved in shrimp immune response to bacteria and Enterocytozoon hepatopenaei (EHP) infection in Palaemon carinicauda. Fish & Shellfish Immunology. 139. 108871–108871. 6 indexed citations
10.
Wei, Shu‐Yi, Jinhua Chen, Weili Wang, et al.. (2022). Vinculin phosphorylation impairs vascular endothelial junctions promoting atherosclerosis. European Heart Journal. 44(4). 304–318. 32 indexed citations
11.
Jin, Jian‐Yue, Weili Wang, Hao Yu, et al.. (2020). Radiation Induced Lymphopenia is Associated with the Effective Dose to the Circulating Immune Cells (EDIC) for Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 108(3). e57–e58. 2 indexed citations
12.
Kong, Feng‐Ming, Chen Hu, Weili Wang, et al.. (2020). RTOG0617 to Externally Validate Blood Cell ERCC1/2 Genotypic Signature as a Radiosensitivity Biomarker for Both Tumor and Normal Tissue for Individualized Dose Prescription. International Journal of Radiation Oncology*Biology*Physics. 108(3). S2–S2. 3 indexed citations
13.
Wang, Weili, Lei Huang, Jian‐Yue Jin, et al.. (2019). A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non–Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease. Clinical Cancer Research. 26(1). 282–289. 22 indexed citations
14.
Yu, Hao, Huanmei Wu, Weili Wang, et al.. (2019). Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer. Clinical Cancer Research. 25(14). 4343–4350. 19 indexed citations
15.
Wang, Weili, Lei Huang, Jian‐Yue Jin, et al.. (2018). IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients. PMC. 1 indexed citations
16.
Wang, Weili, Lei Huang, Jian‐Yue Jin, et al.. (2017). IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients. Cancer Research. 78(3). 809–816. 54 indexed citations
17.
Song, Xin, Hui Song, Hongwei Li, et al.. (2015). Prognostic analysis of 53 patients with multiple primary upper gastrointestinal cancer. 27(1). 44–46. 1 indexed citations
18.
Chu, Yu‐Te, et al.. (2011). Inhibitory effects of albuterol and fenoterol on RANTES and IP‐10 expression in bronchial epithelial cells. Pediatric Allergy and Immunology. 22(4). 431–439. 9 indexed citations
19.
Liang, Tao, Lingqing Wang, Zhongyi Chong, et al.. (2010). Influence of Slope and Rainfall Intensity on the Rare Earth Elements and Phosphorous Loss from Soil with Surface Runoff. Yingyong jichu yu gongcheng kexue xuebao. 18(5). 741–749. 4 indexed citations
20.
Wang, Weili, et al.. (2005). Clinical study on expression of retinoic acid receptors in breast cancer tissues. 25(2). 118–120. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026